Tag: HRT

The Great Menopause Myth by Kristin Johnson: Summary, Key Ideas & Review

Book in one sentence: Johnson and Claps take a blowtorch to the comforting lies women are told about menopause, and to the wellness industry that profits from keeping them in the dark.

What Is The Great Menopause Myth About?
What Does Menopause Actually Do to Your Weight?
Why the “Just White-Knuckle Through It” Advice Falls Apart
What the WHI Study Actually Said (And What Got Left Out)
Is The Great Menopause Myth Worth Reading?
Books Like The Great Menopause Myth

What Is The Great Menopause Myth About?

Picture the menopause content ecosystem right now: podcasts, Instagram feeds, telemedicine platforms, celebrity supplement lines. Some of it says embrace your symptoms, they’ll pass. Some says lower your cortisol and take these adaptogens. Almost none of it explains why, by age sixty, women match or exceed men in rates of cardiovascular disease, cognitive decline, and osteoporosis.

That gap is what Kristin Johnson and Maria Claps built this book to close. The two are founders of Wise & Well, a women’s health practice they started after their own frustrating encounters with conventional menopause care. Johnson is a former attorney with board certifications in nutrition and holistic health; Claps holds credentials in functional diagnostic nutrition. Neither is a physician, which is worth noting upfront. But they’ve spent a decade working alongside frontier medical providers, digging into patient outcome data, and sitting on the clinical advisory board of a nonprofit trying to change the standard of care for menopausal women. They write with the confidence of people who have seen what different approaches actually produce.

The central claim is both simple and uncomfortable: the current menopause conversation is focused on the wrong target. Hot flashes, night sweats, brain fog, the “midlife belly.” All symptoms of a whole-body signaling loss, not cosmetic inconveniences to ride out. Estrogen and progesterone receptors exist in the brain, heart, bone, skin, gut, bladder, immune system, and more. When those hormones decline, every one of those systems gets the message at once. The book argues that treating menopause as a temporary passage, or as a feminist act of acceptance, leaves women unprepared for the chronic disease trajectory that begins quietly in their forties and accelerates through their fifties.

What Does Menopause Actually Do to Your Weight?

A lot of women arrive at perimenopause convinced they’re doing everything right (same eating, same exercise) and still watch the scale climb and the belly expand. Johnson and Claps spend real time on this, and the explanation is more mechanistic than most women get from their doctors.

Estradiol and progesterone are metabolically protective. Both speed up the rate at which you burn calories. Estradiol plays a specific role in keeping blood sugar stable by improving insulin sensitivity, suppressing hunger through leptin and ghrelin signaling, and supporting adiponectin, the hormone that enables fat loss. When estradiol drops, all of that changes: glucose processing becomes impaired, insulin resistance creeps in, hunger signals go haywire, and fat storage shifts from hips and thighs to the abdomen (visceral fat, which carries the highest health risk).

Then there’s muscle. Estradiol receptors line muscle cells and regulate muscle protein synthesis. Declining estrogen means the body progressively swaps fat for muscle, slowing metabolic rate further. Johnson and Claps describe this as a cascade rather than a single event:

Declining estrogen impairs glucose handling
Impaired glucose handling leads to insulin resistance
Insulin resistance increases fat storage, especially visceral fat
Dysfunctional hunger hormones lead to overeating
Muscle loss slows the metabolic rate
Poor sleep (also hormone-driven) spikes cortisol, which triggers more fat storage and more overeating

The book takes direct aim at the “less food, more cardio” reflex most women default to when the weight starts shifting. According to Johnson and Claps, this response reliably makes things worse: it creates a catabolic environment that accelerates muscle loss, impairs recovery, and drives women toward fast-energy carbs and caffeine to compensate. Resistance training and adequate protein (more than most women are eating) are the non-negotiable interventions. Not as an aesthetic choice. As metabolic medicine.

“The scale should never be the sole determinant of a woman’s state of health. We have seen plenty of ‘thin’ women who are prediabetic with high inflammation markers, and we have seen plenty of women 10 to 20 pounds overweight who have beautiful lipids, blood sugar, and inflammation status.”

The practical takeaway isn’t that menopause makes weight gain inevitable. The book’s argument is the opposite: the cascade is largely modifiable if you understand what’s driving it and address the right levers. Thin is not the goal. Metabolically healthy is the goal. Those two things are not the same.

Why the “Just White-Knuckle Through It” Advice Falls Apart

Johnson and Claps give a name to the problem: the menopause gold rush. With an estimated 1.2 billion women worldwide becoming postmenopausal by 2030, the market opportunity is enormous, and investors, wellness brands, and social media influencers have rushed in. The result is a proliferation of interventions that address visible symptoms and aging aesthetics without touching the underlying disease risk.

The book draws a line between two approaches to hormone therapy that most women don’t know to ask about:

MHT (menopausal hormone therapy) is symptom-focused. The goal is to suppress hot flashes and vaginal dryness using the lowest dose that relieves discomfort. This is the standard-of-care approach most providers use. The dose is calibrated to feeling better, not to the levels of estrogen that protect bone, brain, and cardiovascular function.

HRT (hormone replacement therapy), as Johnson and Claps use the term, is restoration-focused. The goal is to approximate premenopausal hormone levels in order to preserve organ function and interrupt the chronic disease trajectory. This requires higher, individually calibrated doses, regular blood testing (not just symptom tracking), and attention to which types and delivery routes are used.

That gap matters. A dose sufficient to stop a hot flash is often not sufficient to protect your bones, brain, or heart. If your provider’s measure of success is whether you feel better, you may feel better while remaining at elevated risk. Johnson and Claps note that 80 percent of medical residents report discomfort discussing or treating menopause, so the conversation that ends with a low-dose patch and a three-month follow-up is often the most care women can expect from the standard system.

Their prescription for this gap is metabolic health first. The “hormones need a healthy host” metaphor runs through the middle section of the book: you wouldn’t invite houseguests into a disorganized home. Hormones are the guests; metabolic health is the house. Studies they cite show that adding hormones without addressing insulin resistance, chronic inflammation, and gut dysfunction can increase cancer and cardiovascular risk rather than reduce it. So nutrition, resistance training, sleep, and stress management are the foundation. Not optional lifestyle additions. Clinical prerequisites for hormone therapy to work as intended.

What the WHI Study Actually Said (And What Got Left Out)

If you’ve ever been told by a doctor that hormone therapy causes breast cancer, or had a prescription declined because of “the studies,” Chapter Eleven is the one to hand them.

The Women’s Health Initiative, which published alarming results in 2002, studied women with an average age of 63 (more than a decade past the average age of menopause). It used conjugated equine estrogen (from pregnant horse urine) combined with a synthetic progestin (medroxyprogesterone acetate). When preliminary results showed an apparent breast cancer risk increase in one arm of the trial, the story became: Estrogen Causes Cancer. Millions of women stopped their prescriptions. Most physicians stopped prescribing.

What didn’t make the headlines:

The absolute risk increase was 0.08 percent (from 4 women per thousand per year to 5)
The estrogen-only arm of the same study showed a 23 percent lower rate of breast cancer than the placebo group (a finding that received almost no media attention)
WHI investigators themselves have since published corrections clarifying that the findings cannot be applied to younger, healthier women in the perimenopause window

The book introduces what researchers now call the “timing hypothesis.” Estrogen protects healthy cells; it cannot restore function that’s already been lost. Beginning hormone restoration within ten years of menopause (ideally during perimenopause) yields cardiovascular and neuroprotective benefits that starting later cannot provide. The window is real, and most women aren’t being told it exists.

Johnson and Claps aren’t arguing that every woman should take hormones. They’re arguing that the widespread provider reluctance rooted in a twenty-year misreading of a flawed study isn’t evidence-based, and that women deserve to know that when they’re making decisions about their own care.

Is The Great Menopause Myth Worth Reading?

Read this if you’re in your forties or fifties, feel like the information you’ve been handed about menopause is incomplete, and want an accessible book that connects symptoms to underlying biology rather than treating them as separate problems to manage. Especially useful if you’ve been refused or discouraged from hormone therapy and want to understand the WHI story in full, or if you want a framework that integrates metabolic health and hormone restoration rather than treating them as separate tracks.

Skip it if you want a single-topic deep dive. For cognitive and Alzheimer’s risk specifically, Lisa Mosconi’s The Menopause Brain goes further and has the neuroimaging data behind it. For a more integrative approach that includes non-hormonal options, Suzanne Gilberg-Lenz’s Menopause Bootcamp is more thorough. Johnson and Claps are comprehensive but not always granular. Some chapters cover a lot of ground quickly.

One caveat: Johnson and Claps are functional nutritionists and health coaches, not physicians or endocrinologists. That doesn’t invalidate their research synthesis (much of which is more current than what you’ll find in popular physician-authored books). But for clinical decisions around hormone therapy, working with a qualified provider remains essential. The authors say so explicitly, and it’s worth taking seriously.

Books Like The Great Menopause Myth

Book	Author	Best For
The Hormone Myth	Robyn Stein DeLuca	Debunking hormonal hysteria with psychological research
Menopause Bootcamp	Suzanne Gilberg-Lenz	Integrative approach, inclusive of non-HRT options
The Science of Menopause	Leah Kaye	Clinical deep dive, evidence-first format
The Menopause Brain	Lisa Mosconi	Cognitive and Alzheimer’s risk, neuroimaging data
Unlock Your Menopause Type	Heather Hirsch	Individualized approach by symptom pattern

September 1, 2024

The XX Brain by Lisa Mosconi: Summary, Key Ideas & Review

Book in one sentence: A neuroscientist who scans brains for a living makes the case that Alzheimer’s is largely preventable in women, if we stop treating women’s brains like smaller male ones.

What Is The XX Brain About?
Why Do Women Get Alzheimer’s at Twice the Rate?
What Does Estrogen Actually Do in the Brain?
What Should Women Actually Eat for Brain Health?
Is The XX Brain Worth Reading?
Books Like The XX Brain

What Is The XX Brain About?

If you’ve ever walked into a room and forgotten why you went there, your doctor probably smiled and said “that happens to everyone.” Maybe it does. But Lisa Mosconi’s research suggests it happens more to women, more often, starting earlier. There’s a measurable biological reason why. She’s not guessing. She’s been scanning women’s brains for two decades at Weill Cornell Medicine, where she’s associate director of the first Alzheimer’s Prevention Clinic in the United States.

Here’s the statistic she opens with: two-thirds of all Alzheimer’s patients in the U.S. are women. A 60-year-old woman is twice as likely to develop Alzheimer’s in her remaining lifetime as she is to develop breast cancer. Her mother developed it. Her grandmother developed it. She wrote this book because medicine has spent generations treating women’s brains as though they were simply smaller male brains, and the consequences of that assumption are now showing up in the numbers.

The XX Brain makes a specific, evidence-backed argument: the brain fog, memory slips, sleep disruption, and mood changes that women experience in perimenopause are not “just aging.” They show up on brain scans. They correspond to real metabolic changes. And they are, in many cases, the earliest detectable signal of Alzheimer’s risk (occurring 20 to 30 years before anyone would ever be diagnosed). The good news buried inside that alarming fact is that the window for doing something about it is long, and most of the interventions are free.

Why Do Women Get Alzheimer’s at Twice the Rate?

The standard answer is that women live longer. Mosconi’s answer is: that’s not the whole story.

Women carry a distinct Alzheimer’s vulnerability that has nothing to do with longevity and everything to do with biology. Women are more likely to carry the APOE-4 gene variant (the main genetic risk factor for Alzheimer’s). They’re more likely to develop tau pathology. Their hippocampuses (the brain’s memory center) atrophy faster once the disease begins. And because women’s verbal memory systems are so strong, early Alzheimer’s pathology can be masked for years while it accumulates silently.

There’s also a myth Mosconi dismantles cleanly: Alzheimer’s is not genetic destiny. Only 1-2% of cases come from rare deterministic mutations. For the remaining 98%, risk is built from a combination of genetics, hormones, medical history, and daily choices over decades. APOE-4 is a susceptibility factor, not a sentence. The modifiable risks (cardiovascular disease, type 2 diabetes, obesity, hypertension, chronic stress, sleep deprivation, poor diet) account for a substantial share of Alzheimer’s cases. Every one of them is addressable.

The hard part is timing. By the time someone gets an Alzheimer’s diagnosis, pathology has been accumulating for two or three decades. The brain scan changes Mosconi’s lab detects in perimenopausal women (reduced glucose metabolism in memory and reasoning centers) look strikingly similar to what they see in early Alzheimer’s. That’s not a reason to panic. It’s a reason to act in your 40s, not your 70s.

What Does Estrogen Actually Do in the Brain?

Most people think of estrogen as a reproductive hormone. That framing is wrong, and Mosconi spends the first quarter of the book correcting it.

Estrogen is a neurological hormone. Estrogen receptors are distributed throughout the brain: the hippocampus, prefrontal cortex, amygdala, and brainstem. Through those receptors, estrogen governs how the brain fuels itself, manages inflammation, builds new synaptic connections, and regulates serotonin, GABA, and endorphins. Mosconi calls it the brain’s “master regulator.” When it declines during perimenopause, the brain’s energy supply falters and its defenses weaken.

“Estrogen is a ‘master regulator’ in the female brain, serving many roles that actually have nothing to do with reproduction, but rather everything to do with energy.”

This reframe matters because it changes how to interpret what’s happening during the menopausal transition. Perimenopause is not just a reproductive event. It’s a neurological one. The brain fog is real. The memory lapses are real. The mood volatility is real. These are not character flaws or signs that you’re “losing it.” They’re measurable metabolic changes that show up on imaging.

Mosconi also takes on the hormone therapy mess left by the 2002 Women’s Health Initiative trials, which spooked a generation of women and doctors away from menopausal hormone therapy (MHT). The WHI studied women averaging 63 years old (more than a decade past menopause) given synthetic progestins and conjugated equine estrogen derived from pregnant mares. The results were applied to all women, everywhere, forever. That was the error. The “timing hypothesis,” supported by substantial research since, holds that MHT begun during perimenopause or early menopause (when estrogen receptors are still active) carries a very different risk profile. Women who start it in that window show reduced cardiovascular risk, preserved cognitive function, and in several studies, reduced Alzheimer’s risk. Transdermal estradiol and micronized progesterone carry less risk than the formulations studied in the WHI. Mosconi isn’t telling every woman to take hormones. She’s giving women enough information to have a real conversation with their doctor.

What Should Women Actually Eat for Brain Health?

Mosconi is a neuroscientist who studies diet and the brain, so her nutrition chapter is grounded in actual research rather than the usual “eat whole foods” non-advice. The framework is built on Mediterranean and MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet research, with adjustments specific to women’s hormonal and metabolic needs.

The headline findings:

Dark leafy greens, daily. One serving per day is associated with cognitive function 11 years younger than in women who rarely eat them. The active components are vitamins K, folate, and lutein.
Berries, twice a week. Blueberries and strawberries specifically, based on a 16,000-woman study showing 2.5 years of slower cognitive aging with two or more weekly servings. Flavonoids are the mechanism.
Fatty fish, 2-3 times a week. Omega-3s (EPA and DHA) are critical for brain membrane structure and anti-inflammatory signaling. Low omega-3 index in women predicts accelerated cognitive aging.
Fiber, 25+ grams daily. Women’s estrogen metabolism depends on gut bacteria that require adequate fiber. Fiber also stabilizes blood glucose, which directly reduces brain inflammation.
Olive oil as primary fat. The Mediterranean-MIND trials with the strongest cognitive outcome data all center on olive oil.

The surprises are what to cut. Refined grains, added sugar, ultra-processed food: expected. Alcohol is the one that lands differently. Even one drink per day is associated with measurable brain shrinkage in women. The “a glass of wine is protective” narrative does not hold up in neuroimaging research. Mosconi doesn’t moralize about it; she just reports what the scans show.

On exercise: 40 minutes of brisk walking three times per week grew hippocampal volume by 2% in one year in a clinical trial she cites (Kirk Erickson’s 2011 study). The stretching-only control group showed the normal 1-2% annual brain shrinkage. Walking as if late for a meeting, three times a week, rolled back cognitive age by approximately two years. No gym, no equipment, no elite fitness required.

Sleep and stress get real treatment too. Chronic cortisol exposure damages brain tissue. Seven to nine hours of sleep is when the glymphatic system flushes amyloid and tau (the proteins that cause Alzheimer’s). Social isolation is an independent Alzheimer’s risk factor of similar magnitude to cardiovascular disease. Scheduling time with friends is, by this research, a legitimate brain health intervention.

Is The XX Brain Worth Reading?

Read this if you’re a woman in your 30s, 40s, or 50s who wants to understand what’s actually happening in your brain as your hormones shift. If you’ve ever been dismissed when reporting brain fog, memory issues, or mood disruption around perimenopause. If you have a maternal family history of Alzheimer’s and want a concrete prevention framework. If you’ve avoided or feel confused about hormone therapy because of the 2002 WHI scare.

Skip it if you want a quick-read checklist with no science. Mosconi writes for an educated general audience, but this is not a 10-minute skim. She is translating FDG-PET imaging and genomic research into plain language, and that takes some patience.

One caveat: Published in 2020, so the MHT and APOE-4 research landscape has continued to move. Readers with specific questions about hormone therapy should check current clinical guidelines alongside this book, not instead of them. Mosconi’s follow-up, The Menopause Brain (2024), deepens the hormonal transition content with more recent data.

Books Like The XX Brain

Book	Author	Best For
The Menopause Brain	Lisa Mosconi	Mosconi’s 2024 follow-up focused on the menopausal transition specifically
Brain Food	Lisa Mosconi	Her 2018 book with deeper nutritional science for brain health
Brain Body Diet	Sara Gottfried, MD	Hormonal drivers of women’s brain and metabolic health
The Menopause Manifesto	Jen Gunter, MD	Evidence-based guide to menopause without the fear
Hormone Intelligence	Aviva Romm, MD	Integrative approach to women’s hormonal health across the lifespan

April 8, 2024

The Science of Menopause by Philippa Kaye: Summary, Key Ideas & Review

Book in one sentence: A UK GP strips the misinformation out of menopause and replaces it with the actual evidence: hormones, HRT, symptoms, metabolism, and all.

What Is The Science of Menopause About?
What Does Menopause Actually Do to Your Metabolism?
Is HRT Really as Dangerous as Everyone Says?
What About the Symptoms Nobody Talks About?
Is The Science of Menopause Worth Reading?
Books Like The Science of Menopause

What Is The Science of Menopause About?

You ask your doctor about HRT and she says she’s “not really comfortable with it.” You search online and get 457 million results. You find a Facebook group and come away more confused than before. This is the information environment most women are navigating when their bodies start behaving in ways they don’t recognize.

Dr. Philippa Kaye is a UK GP (general practitioner) and the author of nine books on women’s health. She wrote this one because her consulting room was full of women who didn’t understand what was happening to them, assumed their symptoms were just aging, or were refusing treatments because of clinical trial data from 2002 that was badly misapplied for two decades. The book is structured as a Q&A, so you can open it to “Why am I gaining weight?” or “What is genitourinary syndrome?” and get a direct clinical answer. You can also read it front to back and build a coherent picture of the whole transition.

At 224 pages, it reads more like a medical briefing than a book. Dense, well-organized, no filler. The tone is what you’d want from a doctor who actually has 30 minutes to talk to you: clear, evidence-grounded, and without an agenda beyond helping you make informed decisions.

What Does Menopause Actually Do to Your Metabolism?

This is the section that matters most if weight and eating have been part of your story.

The average adult gains 1 to 1.5 pounds per year from early adulthood through middle age. That’s not a perimenopause problem specifically. It’s what happens when muscle mass gradually declines with age and nobody replaces it. Muscle burns more calories at rest than fat does, so losing muscle without adding it back creates a slow caloric gap even when nothing else changes. Perimenopause accelerates this process.

Estrogen also controls where fat gets deposited. As levels fall, fat shifts from the hips and thighs toward the abdomen (visceral fat), and the body simultaneously tries to produce an alternative form of estrogen called estrone from adipose tissue. Visceral fat carries higher metabolic and cardiovascular risk than subcutaneous fat. This is why body composition changes in midlife can feel so different from earlier weight gain (same number on the scale, different distribution, different implications).

Kaye’s practical recommendation is strength training twice per week as a specific clinical priority, not a general wellness suggestion. The goal isn’t aesthetics. It’s preserving the metabolic engine that’s been quietly losing mass since your thirties. For anyone whose relationship with food and weight has been complicated, this framing is worth sitting with: the changes aren’t a personal failure, and the lever isn’t less food. It’s more muscle.

“With a lower muscle mass, even if you consume the same amount of food/calories, you will gain weight.” (Philippa Kaye)

Is HRT Really as Dangerous as Everyone Says?

The short answer is: the HRT most women are afraid of is not the HRT being prescribed now.

In the early 2000s, a major US study called the Women’s Health Initiative (WHI) published results suggesting that HRT increased risks of breast cancer and cardiovascular disease. Prescriptions dropped by 50 percent almost overnight. The fear stuck, and it’s still in the room when most women have this conversation with their doctors today.

Here’s what the coverage got wrong. The average participant in that study was 63 years old. These were not perimenopausal women in their mid-forties. The study also used oral synthetic estrogen and synthetic progestins, formulations that look nothing like what evidence-based practitioners currently prescribe. Kaye walks through the key distinctions:

Transdermal estrogen (gel, patch, or spray) bypasses the liver and carries no increased risk of blood clots or stroke. Oral estrogen does carry that risk. Delivery route matters clinically.
Micronized progesterone (sometimes called Utrogestan or Gepretix) is body-identical and plant-derived. It carries a much lower breast cancer signal than the synthetic progestins studied in the WHI.
Timing matters. HRT started within 10 years of menopause onset may be cardioprotective. Starting much later, in women who already have established cardiovascular disease, carries a different risk profile.

The WHI findings were real for that population, using those formulations, at those ages. The harm was in applying those conclusions to a completely different group. Kaye doesn’t demonize the researchers. She frames this as a clinical literacy problem, one that has cost women years of unnecessary suffering, bone fractures, and preventable cardiovascular events. Undertreated menopause is its own health crisis, and she makes that case with specifics.

For women who can’t or don’t want to use HRT, the non-hormonal options get the same rigorous treatment. Fezolinetant (brand name Veoza, FDA-approved 2023) is the first non-hormonal prescription drug specifically targeting the mechanism of hot flashes. SSRIs and SNRIs reduce hot flash frequency by 30 to 60 percent. CBT is clinically validated for hot flashes, insomnia, anxiety, and depression. The book rates each option by evidence quality, which is more useful than a list.

What About the Symptoms Nobody Talks About?

Hot flashes get the most airtime, but Kaye explains why they happen in a way most books skip. The hypothalamus keeps body temperature within a narrow range. Estrogen normally moderates a peptide called neurokinin B (NKB). As estrogen falls, NKB overstimulates the thermoregulatory center via NK3 receptors, and the brain reads a temperature emergency that isn’t happening. The body launches its heat-dissipation response: vasodilation, flushing, sweating. Core body temperature doesn’t actually rise. You’re cooling something that isn’t hot. Understanding this mechanism explains why fezolinetant works without hormones: it blocks the NK3 receptor directly.

Mood symptoms are consistently misidentified. Perimenopausal women are 40 percent more likely to be diagnosed with depression than premenopausal women, and mood changes (anxiety, irritability, low mood, brain fog) often show up before hot flashes do. Women in their mid-forties get put on antidepressants with nobody connecting the symptoms to hormonal fluctuation. Estrogen supports serotonin synthesis and receptor sensitivity; progesterone acts on GABA receptors. As both hormones decline and swing erratically (Kaye’s phrase: “a roller-coaster”), the neurochemical scaffolding for mood stability is progressively removed. HRT can resolve hormonally-driven mood symptoms that antidepressants alone won’t touch.

Genitourinary syndrome of menopause (GSM) is the symptom with the worst visibility gap. It covers vaginal dryness, painful sex, recurrent UTIs, and urinary urgency, and it affects over half of postmenopausal women. Unlike hot flashes, which often ease over time, GSM is progressive without treatment. Vaginal estrogen is the definitive fix: local application, minimal systemic absorption, safe for most women including breast cancer survivors, reduces UTI frequency by more than 50 percent in studies. It takes three to six months for full effect and should be continued long-term because the condition is chronic. Women don’t report it (stigma, or the assumption that sex is just supposed to hurt now), and clinicians often don’t ask. The silence around GSM costs women years of avoidable suffering that is, in most cases, straightforwardly treatable.

Is The Science of Menopause Worth Reading?

Read this if you want one reliable, clinical reference on perimenopause and you’re done wading through wellness influencer content that can’t tell you why hot flashes happen or what micronized progesterone actually is. Kaye treats readers as adults. For anyone who has struggled with weight and wants to understand the metabolic mechanics of this transition (not just “eat less, exercise more”), the muscle mass and fat distribution sections are unusually well-sourced and direct. If you’re on a GLP-1 medication and navigating perimenopause at the same time, the sections on muscle preservation and metabolic rate are directly relevant to how both interventions interact.

Skip it if you want a diet plan, a step-by-step protocol, or extended personal narrative. This is a reference book. The lifestyle chapter is evidence-grounded but concise: it points to what works and why, without building out full programs. Also worth noting: Kaye is a UK GP, so her treatment recommendations follow NICE guidelines, which sometimes differ from US FDA approvals. The distinctions are flagged in the text, but you’ll need to translate some of it.

One caveat: The reader rating reflects the fact that some readers found it too dense or too clinical. That’s accurate. It reads like a thorough GP who won’t waste your appointment. Whether that’s a feature or a bug depends entirely on what you showed up for.

Books Like The Science of Menopause

Book	Author	Best For
Menopause Bootcamp	Suzanne Gilberg-Lenz	A warmer, more lifestyle-forward companion to Kaye’s clinical lens
The Menopause Brain	Lisa Mosconi	Goes deep on the cognitive and neuroprotective angle Kaye covers briefly
The Great Menopause Myth	Kristin Johnson	Functional medicine approach, more integrative, less evidence-rigorous
The Power of Hormones	Max Nieuwdorp	Broader hormonal context, useful for understanding the full endocrine picture
It’s Your Hormones	Geoffrey Redmond	US-focused, clinical, good for understanding HRT formulation options in more depth

January 3, 2024

The Hormone Shift by Tasneem Bhatia: Summary, Key Ideas & Review

Book in one sentence: An integrative medicine physician maps the full hormone arc from adolescence to post-menopause and offers a sequenced, five-phase protocol for midlife women whose symptoms keep getting dismissed as “just aging.”

What Is The Hormone Shift About?
Why Does Midlife Weight Gain Feel Different?
How Does Your Gut Control Your Hormones?
What Are “Dirty Hormones” and Why Does It Matter?
Is The Hormone Shift Worth Reading?
Books Like The Hormone Shift

What Is The Hormone Shift About?

You’ve probably had the experience of eating the way you always ate, moving the way you always moved, and watching your body respond in ways it never did before. Weight collecting around your middle. Sleep unraveling for no clear reason. A fog that settles in around 3pm and won’t lift. You go to your doctor, she runs labs, and then comes the sentence: “Everything looks normal.”

Tasneem Bhatia, MD (“Dr. Taz”), wrote this book for that moment. She’s a board-certified integrative and holistic medicine physician who founded CentreSpringMD in Atlanta after spending fifteen years watching women cycle through the same pattern: symptoms, dismissal, a prescription for anxiety or sleep, repeat. She’s also been on the receiving end of that dismissal herself. At twenty-eight, her hair was falling out, she’d gained weight, her knees ached, and six separate specialists told her she was fine before she crashed her car after a blood pressure drop caused by a medication none of them had thought to check for interactions. That experience sent her into Chinese medicine, Ayurveda, and Andrew Weil’s Integrative Medicine Fellowship. The book comes from that foundation, not from a wellness brand looking for content.

The Hormone Shift lands in a gap between two frustrating options: conventional medicine, which tends to minimize or medicate symptoms without investigating the underlying hormonal picture, and the wellness-influencer world, which offers seed cycling and moon rituals without clinical grounding. Bhatia’s approach is both more rigorous than the second and more holistic than the first. She provides specific lab ranges, supplement dosing, and a structured thirty-day protocol. She also takes Chinese medicine and emotional patterns seriously as clinical data. The combination won’t satisfy everyone, but for women in perimenopause who’ve been failed by the conventional approach, it’s worth the friction.

Why Does Midlife Weight Gain Feel Different?

A calorie-deficit approach that worked at thirty frequently stops working at forty-five. Bhatia’s explanation for this isn’t complicated, but it’s rarely given plainly: your hormonal environment has shifted, and your body is responding to different signals than it was before.

Perimenopause (roughly ages 39 to 55 in Bhatia’s framing) involves a declining estrogen-progesterone ratio, rising cortisol sensitivity, insulin resistance that accumulates quietly for years, and thyroid changes that often fall within “normal” lab ranges while producing real symptoms. Each of these independently affects body composition. Together, they create the specific pattern most midlife women recognize: belly fat that wasn’t there before, cravings that are harder to override, and effort that doesn’t produce results.

The craving map is one of the more useful sections of the book. Bhatia ties specific nutrient deficiencies and hormonal states to specific craving patterns:

Low progesterone pulls toward salt
Low estrogen pulls toward fat
Low iron pulls toward sugar (quick energy)
Thyroid disruption produces craving variability that doesn’t follow any predictable pattern

None of these are willpower failures. They’re the body signaling an imbalance. Restriction-based responses to these cravings often make the underlying problem worse, because severe caloric restriction depletes progesterone, raises cortisol, and can worsen the estrogen dominance that’s driving the weight in the first place.

Her alternative is what she calls biorhythmic eating: eating when genuinely hungry, anchoring meals around 20 to 30 grams of protein every three to four hours for blood sugar stability, and keeping a twelve-hour overnight fast as a baseline practice. It’s less a diet than an attempt to work with the body’s hormonal timing rather than override it with external rules.

Bhatia also structures the whole book around a Five Power Types framework, a life-stage map of the female hormonal journey. The stages run from Rock Star (13 to 19), through Hustler (20 to 28), Superstar (29 to 38), Superwoman (39 to 55), and Commander (56+). The practical value is that it stops treating perimenopause as an isolated event. The hormonal patterns in your forties were set up in your twenties and thirties, and the conditions you’re managing now in menopause were shaped by what accumulated before. Knowing your Power Type tells you which hormonal layer to investigate first, rather than throwing every available intervention at the problem simultaneously.

How Does Your Gut Control Your Hormones?

Most hormone books treat hormone replacement as the logical first step when symptoms appear. Bhatia’s structural argument is that this is exactly backwards, and the reasoning is biochemical, not philosophical.

The gut microbiome contains a community of bacteria called the estrabolome. These bacteria produce enzymes that determine how estrogen is metabolized and recycled. When the microbiome is disrupted by antibiotics, processed food, alcohol, stress, or chronic inflammation, the estrabolome becomes dysfunctional. Estrogen then either recirculates in forms that drive excess (estrogen dominance) or gets metabolized poorly, regardless of how much estrogen the body is actually producing.

“Your gut is ground zero for your health. It processes your food. It gets rid of waste. It produces neurotransmitters. It fights off toxins. And it plays a pivotal role in hormone balance.”

The practical implication: adding hormones to a compromised gut means the new hormones get mishandled by the same dysfunctional system that’s already mishandling your endogenous hormones. This is why her thirty-day protocol puts gut repair before hormone correction, always.

The gut-symptom pattern table she includes is worth examining carefully:

Chronic constipation maps to estrogen dominance and high insulin
Diarrhea and IBS map to low progesterone and sluggish thyroid
Bloating maps to thyroid disorders and estrogen/progesterone imbalance
Reflux maps to high progesterone and low estrogen

If you’ve been treating these as digestive problems while also experiencing hormonal symptoms, you may be looking at a single root cause from two different angles. That’s the core observation Bhatia keeps returning to throughout the book: conventional medicine treats these as separate domains, and that separation is where women fall through the cracks.

What Are “Dirty Hormones” and Why Does It Matter?

“Dirty hormones” is Bhatia’s term for hormone metabolites, specifically the breakdown products of estrogen that accumulate when the liver can’t clear them efficiently. These metabolites aren’t inert. They act on the body in ways that amplify estrogen dominance, raise DHT (the androgen behind hair loss and acne), and worsen insulin dysregulation. They’re a direct driver of the weight, mood, and body-composition symptoms that midlife women bring to their doctors.

The liver becomes overburdened by what modern life piles on it: alcohol, processed foods, acetaminophen (Bhatia mentions this specifically), fragranced personal care products, plastics, and pesticide residues. No single exposure is catastrophic in isolation. The aggregate load in a typical modern woman’s life is a different order of magnitude than prior generations carried, and the liver, which is also the primary organ for hormone detoxification, bears the cost.

Practical reduction starts with the least glamorous interventions. Switch personal care products to fragrance-free and paraben-free. Use glass or stainless steel for food storage. Filter your water. Choose organic for the EWG’s dirty dozen produce list. Reduce alcohol (not necessarily eliminate it, but reduce). Add cruciferous vegetables, dandelion greens, beets, and garlic to support liver function.

The section on DIM (diindolylmethane), found in cruciferous vegetables and available as a supplement, is one of the most actionable in the book. DIM supports the liver’s Phase 1 and Phase 2 detoxification of estrogen, shifting metabolism away from the more inflammatory estrone metabolites toward safer excretion pathways. For women with estrogen dominance symptoms, such as breast tenderness, heavy periods, weight gain in the hips and thighs, or fibroid growth, this is a high-leverage, no-prescription-required intervention.

The emotion-hormone section gets its own chapter, and it’s worth taking seriously even if you’re skeptical of TCM frameworks. The core claim is documented physiology: chronic stress elevates cortisol, which competes with progesterone at receptor sites, suppresses thyroid function, raises insulin, and impairs gut healing. Hormonal imbalances in turn produce anxiety, depression, and emotional volatility. The bidirectional loop is not speculative. What Bhatia adds, from her clinical observation, is that major psychological losses (divorce, betrayal, death of a parent) tend to be followed by a hormonal or autoimmune diagnosis approximately eighteen months later. She’s seen this often enough that she anticipates it. Her explanation draws on psychoneuroendocrinology and early mitochondrial science. The evidence is preliminary but coherent.

Is The Hormone Shift Worth Reading?

Read this if you’re in your late thirties, forties, or fifties and you’re experiencing weight changes, sleep disruption, mood shifts, or fatigue that your doctor has attributed to stress or aging. Read it if you’ve been told your labs are normal while feeling clearly unwell. Read it if you’ve tried calorie restriction and exercise without results and want a more complete picture of what’s actually driving your body composition.

Skip it if you’re already working with a knowledgeable integrative medicine physician who’s running full hormone panels and adjusting your protocol accordingly. The book’s value in that case is more as a conceptual framework than a clinical guide.

One caveat: Bhatia integrates peer-reviewed physiology with TCM frameworks and clinical pattern recognition without always distinguishing between them. The gut-hormone connections and cortisol-progesterone competition are textbook science. The emotion-meridian mapping is more speculative, though it’s clinically consistent with what psychoneuroendocrinology is slowly documenting. Both are useful. They’re not the same level of evidence.

This is a less dense read than Aviva Romm’s Hormone Intelligence, more clinically grounded than most conventional menopause books, and more integrative in its framework than Anna Cabeca’s The Hormone Fix. For women who want a practical entry point into understanding their midlife hormonal picture, it’s a solid starting place.

Books Like The Hormone Shift

Book	Author	Best For
Hormone Intelligence	Aviva Romm, MD	More evidence-focused; stronger on root-cause analysis of modern hormonal dysfunction
The Hormone Fix	Anna Cabeca, DO	Narrower dietary focus; the keto-green approach as a complement to Bhatia’s broader protocol
Menopause Bootcamp	Suzanne Gilberg-Lenz, MD	More conversational; good for women who find Bhatia’s protocol framework dense
The New Menopause	Mary Claire Haver, MD	Strong emphasis on HRT as first-line treatment; less integrative but highly practical
Eat to Thrive During Menopause	Stephanie Huber	Food-forward companion for the dietary aspects of hormone balance

October 26, 2023

Menopause Bootcamp by Suzanne Gilberg-Lenz: Summary, Key Ideas & Review

Book in one sentence: A Harvard-trained Beverly Hills OB-GYN dismantles two decades of hormone therapy fear and hands you the clinical vocabulary to actually advocate for yourself.

What Is Menopause Bootcamp About?
What Does Gilberg-Lenz Say About HRT?
Why Does Menopause Cause Weight Changes?
What About Mental Health and Mood?
Is Menopause Bootcamp Worth Reading?
Books Like Menopause Bootcamp

What Is Menopause Bootcamp About?

Two years before writing this book, Suzanne Gilberg-Lenz decided to stop coloring her hair. Her hairdresser of fifteen years went ahead and mixed up the chestnut dye anyway, without asking. When she questioned him, he said: “You’re not ready.” She spent the next two pages of her introduction unpacking that exchange, because it captures something real about what women face going into this transition: everyone has an opinion, the opinion is usually about looking younger, and nobody asks.

Gilberg-Lenz is a board-certified OB-GYN who trained at Cedars-Sinai and has been running in-person Menopause Bootcamp groups in Southern California for years. She is also a clinical Ayurvedic specialist, which shapes the book’s integrative tone without sacrificing the clinical rigor. What she built in this book is essentially the education her private patients receive, structured around biology, symptoms, mental health, nutrition, movement, and community, in that order.

The “bootcamp” framing is intentional. Rather than treating menopause as something to endure quietly, she positions it as a transition you can study, prepare for, and move through on your own terms. “Your mother’s menopause is not your menopause” is the organizing spirit. The science has changed, the treatment options have expanded, and the cultural silence around the whole thing is costing women their health.

She opens with a number worth sitting with: a 2013 Johns Hopkins survey found that 67% of OB-GYN residents reported limited knowledge of why menopause symptoms occur, 68% didn’t know enough about hormone therapy, and 72% needed to learn more about cardiovascular disease. These are the doctors most women see first. Gilberg-Lenz wrote this book partly because she got tired of watching women come in undertreated, dismissed, and relieved that someone finally asked.

What Does Gilberg-Lenz Say About HRT?

The HRT chapter is the one that will make you want to hand this book to your doctor. It is balanced in a way that most consumer menopause books are not, neither reflexively pro-hormone nor still trembling from the 2002 Women’s Health Initiative fallout.

Here is the short version of what happened with the WHI: The study appeared to show that hormone replacement therapy raised the risk of heart disease and breast cancer. Prescriptions plummeted almost overnight. Women flushed their pills. A generation of doctors stopped recommending it, and millions of women were left to manage severe symptoms with nothing.

What the WHI actually showed, and what got distorted, is the subject of careful unpacking in this chapter. The average participant was 65, meaning most were ten-plus years past their menopausal transition. Many had preexisting cardiovascular disease. The hormones used were Premarin (conjugated equine estrogen) and Provera (a synthetic progestin called medroxyprogesterone acetate), not the body-identical estradiol and micronized progesterone that thoughtful prescribers now use. The study’s conclusions were applied far more broadly than the data warranted.

What the research since then supports:

Transdermal estradiol (patch, gel, spray) carries meaningfully lower clot risk than oral estrogen
Micronized progesterone (sold as Prometrium) appears safer regarding breast cancer risk than synthetic progestins (Gilberg-Lenz avoids synthetic progestins in her own practice for exactly this reason)
The “timing hypothesis”: initiating MHT within 10 years of menopause onset, or before age 60, is associated with cardiovascular protection and possibly cognitive protection
Women who start early are not in the same risk category as the WHI population

Gilberg-Lenz is direct about the limits of this, too. She’s not saying hormones are safe for everyone. She’s saying individual assessment matters, formulation matters, and the blanket fear many women carry is based on data that no longer reflects how MHT is prescribed. Her own framing:

“The conclusion we clinicians draw from this study now isn’t that hormones are actually 100 percent safe; it’s that the data can’t be applied as broadly as we had expected or hoped.”

She also addresses genitourinary syndrome of menopause (GSM) with particular emphasis (the cluster of vaginal dryness, painful intercourse, and recurrent UTIs that affects a large portion of postmenopausal women). Unlike hot flashes, which often diminish over time, GSM worsens without treatment. Low-dose local vaginal estrogen has minimal systemic absorption and is considered safe by major oncology organizations even for most breast cancer survivors. Many oncologists haven’t communicated this to their patients.

Why Does Menopause Cause Weight Changes?

Fat moves. That is the clearest way to describe what happens metabolically during the menopausal transition. Weight that previously distributed to hips and thighs tends to shift to the midsection, insulin sensitivity changes, and the body’s response to food, exercise, and sleep shifts in ways that feel like a betrayal. It is not a personal failure. It is physiology.

Gilberg-Lenz addresses this without catastrophizing and without handing you a diet. The nutrition chapter (Chapter 9, “Eat for Health and Joy”) is one of the most useful for ExcessMatters readers because of what it doesn’t do: it doesn’t give you a meal plan, it doesn’t prescribe macros, and it explicitly warns against the orthorexia she has seen develop in patients who follow rigid clean-eating protocols.

Her nutrition principles for menopause are anchored in blood sugar stability and anti-inflammatory eating:

Protein and fiber at each meal to support blood sugar and reduce hot flash frequency
Plants, omega-3s, and fermented foods as the anti-inflammatory core
Alcohol and ultra-processed foods minimized, not as moral rules but because of how they interact with inflammation, sleep disruption, and hot flash severity

The alcohol point is consistent across multiple chapters. Alcohol disrupts sleep architecture, worsens hot flash frequency and severity, is pro-inflammatory, and accelerates cognitive aging. For women who have used wine as a stress management tool in midlife, she treats this as clinical data rather than a character judgment.

Strength training is presented as non-negotiable for this stage. Not optional, not vanity. It builds bone density (critical as estrogen declines), preserves muscle mass that would otherwise erode, supports metabolic rate, and improves body confidence in ways cardiovascular exercise alone does not. The movement chapter does not suggest punishing your body into a different shape. It makes the case for movement as protective care.

The body image thread running through the whole book is worth naming. The chapter titled “Breaking Free from the Societal Bullshit” is not a feel-good affirmation section. It is a structural argument about ageism, the sexualization of youth, and the cultural silence around menopause that makes this transition feel shameful when it is, in fact, normal. Gilberg-Lenz practices in Beverly Hills (her description: “ground zero of the absolutely insane notion that only women who are young are worthy of attention”) and does not pretend she’s immune to those pressures. What she offers is not “love your body.” It’s a more honest reframe: the shame doesn’t belong to you, and here is why.

What About Mental Health and Mood?

There is a statistic in this book that deserves more attention than it gets. Researchers followed 29 premenopausal women through their final menstrual period and found that in the 24 months surrounding that endpoint, the risk of onset of depression was 14 times as high as during a 31-year premenopausal period. Six of the nine women who became depressed had never had a depressive episode before.

Women struggling through this are not just having a hard time emotionally. Estrogen modulates serotonin, dopamine, and GABA systems directly. When it declines, there are neurological consequences. The mood instability, sudden tearfulness, and rage that many women experience in this transition are partly hormonal, partly treatable by addressing the hormonal shift itself.

Gilberg-Lenz’s clinical sequence for this is one of the most actionable frameworks in the book:

Address physical foundations first: sleep, movement, alcohol, and nutrition each function as direct mental health levers. Many women who have been prescribed antidepressants for menopause-driven mood changes would have responded to treating their night sweats or eliminating nightly wine.
Evaluate whether what remains is hormonal. MHT can function as an antidepressant for hormonally driven mood disorders.
Assess for clinical depression or anxiety that warrants therapy and/or medication independent of the hormonal transition.

The cognitive protection angle also gets serious treatment here. Estrogen has documented neuroprotective effects. The timing hypothesis extends to the brain: MHT initiated early in the transition may reduce Alzheimer’s risk; late initiation may not confer the same benefit. For women with family histories of dementia, she treats this as one of the most consequential treatment decisions in the transition.

She also covers the medical system’s failures directly, in a chapter she titled “Prejudice in Medicine.” Women were systematically excluded from clinical trials for decades. Black women’s pain and self-reports are documented to be discounted in clinical settings. LGBTQIA+ patients face assumptions that impede accurate care. Gilberg-Lenz does not present this as background context. She builds it into the self-advocacy guidance: enter appointments prepared, use clinical language, ask for the reasoning behind any dismissal, and seek a second opinion from a NAMS-certified menopause practitioner if your current provider lacks expertise.

Is Menopause Bootcamp Worth Reading?

Read this if you are in your 40s or 50s and your doctor has minimized your symptoms, if you have avoided the hormone therapy conversation because of fear from the WHI fallout, or if you are experiencing mood changes, sleep disruption, or weight redistribution that feel tied to hormonal shifts and want to understand why. It is also worth reading if you want language and evidence to advocate for yourself more effectively in medical appointments, or if you have a history of estrogen-receptor-positive breast cancer and want to understand what treatment options still exist.

Skip it if you are well past the transition with an established, satisfying care team and are looking for a strictly evidence-based resource with no integrative medicine. Gilberg-Lenz’s Ayurvedic training shapes the book, and while her clinical standards are solid, the integrative framing occasionally outruns its evidence base. Readers who are skeptical of that framework will find moments of friction.

One caveat: The book’s scope is broad (biology, symptoms, mental health, nutrition, movement, supplements, community) and some sections go deeper than others. The GSM section contains genuinely important clinical information that is easy to miss because it is embedded in a longer symptom chapter. If vaginal dryness and painful sex are your primary concerns, you may want to supplement with a specialist consultation alongside this book.

It won’t replace a good doctor. Gilberg-Lenz is clear about that. What it does is make you a much better patient.

Books Like Menopause Bootcamp

Book	Author	Best For
The Menopause Brain	Lisa Mosconi	Deeper dive on cognitive changes, Alzheimer’s risk, and neurological effects of estrogen decline
The New Menopause	Mary Claire Haver, MD	More clinical, less integrative; strong on HRT protocols and symptom management
The Menopause Diet Plan	Hillary Wright & Elizabeth Ward	Focused specifically on nutrition, weight, and metabolic changes during menopause
Unlock Your Menopause Type	Heather Hirsch, MD	Personalized approach to symptom patterns; good companion if Bootcamp feels too broad
Hormone Intelligence	Aviva Romm, MD	Broader hormonal health lens; covers perimenopause and cycle irregularity in more depth

May 18, 2022

Unlock Your Menopause Type by Heather Hirsch: Summary, Key Ideas & Review

Book in one sentence: A Harvard-trained menopause specialist lays out six distinct symptom profiles and builds a personalized treatment plan for each one, because “there isn’t a one-size-fits-all approach to dealing with menopausal discomfort.”

What Is Unlock Your Menopause Type About?
What Are the Six Menopause Types?
What Does Heather Hirsch Actually Say About Hormones?
Why Does This Matter for Weight and Metabolism?
Is Unlock Your Menopause Type Worth Reading?
Books Like Unlock Your Menopause Type

What Is Unlock Your Menopause Type About?

Picture a doctor’s appointment that goes like this: you describe symptoms that have stolen your sleep, your concentration, and your sense of self. Labs come back fine. The doctor says something like “this is normal” and sends you home with nothing. You leave wondering if you are, somehow, the problem.

Heather Hirsch has spent her career treating the aftermath of that appointment. As clinical program director of the Menopause and Midlife Clinic at Brigham and Women’s Hospital in Boston, she sees women who have been bounced around for months or years, collecting diagnoses that don’t fit and suffering through symptoms no one has connected to the obvious culprit. By the time they reach her, many are, in her words, “at the end of their ropes.”

Her book’s core argument is simple and worth stating plainly: women are not all experiencing the same menopause. A framework built on averages and population data will fail most of them, because most of them are not average. Hirsch’s six-type model came out of pattern recognition across thousands of clinical encounters. It is a diagnostic shortcut designed to do what a rushed generalist rarely has time for: match your specific symptom cluster to a specific treatment hierarchy.

The book is clinical, organized, and refreshingly free of wellness-industry noise. Hirsch trained at Harvard and the Cleveland Clinic. She cites the North American Menopause Society guidelines, she names drugs by their actual names, and she tells you when a treatment is well-supported versus still emerging. For a reader who has been burned by social media menopause gurus, that credibility matters.

What Are the Six Menopause Types?

This is the core of the book. The types are based on onset timing, which body systems are most affected, duration, and functional impact. Two types can overlap (she calls that a hybrid).

The Premature Menopause Type covers periods ending before age 40 (or between 40 and 45, which Hirsch calls early menopause). The issue here is not just managing current symptoms. Decades of estrogen deprivation dramatically elevate long-term risk for heart disease, osteoporosis, mood disorders, and cognitive decline. Hormone therapy in this context is physiological replacement, not optional symptom management, and doses are higher to reflect that.

The Sudden Menopause Type arrives via oophorectomy, chemotherapy, radiation, or abrupt ovarian failure. It bypasses the gradual perimenopause transition entirely, dropping estrogen fast and hard. Symptoms tend to be more severe because there was no runway. Hirsch also addresses the psychological dimension: women navigating surgical menopause after cancer treatment are processing identity loss and existential shock alongside hot flashes, and that processing is clinically important.

The Full-Throttle Menopause Type is the simultaneous, everything-at-once presentation: hot flashes, night sweats, sleep disruption, hair loss, weight gain, joint pain, libido loss, brain fog. All at once. Hirsch describes women with this type as feeling “like they’ve been hit by a truck.” Her core treatment strategy here is triage: identify the single most distressing symptom, treat that first, and address downstream effects before layering anything else.

The Mind-Altering Menopause Type shows up mostly from the neck up: brain fog, word-finding difficulties, working memory deficits, anxiety, depression, mood instability. This is the type most likely to be misread as a psychiatric problem, aging, or stress, especially when vasomotor symptoms are minimal. Women with a history of severe PMS, postpartum depression, or prior major depression are at elevated risk for this type. They are also the women most likely to spend years cycling through antidepressants without anyone noting the menopausal connection.

The Seemingly Never-Ending Menopause Type is exactly what it sounds like: one or two symptoms that started at menopause and simply never resolved. Vaginal dryness, painful intercourse, recurrent UTIs, occasional hot flashes. Six years out. Ten years. Fourteen. Women with this type often stop reporting because they are embarrassed or have resigned themselves to it. The clinical reality is the opposite: genitourinary symptoms worsen over time without treatment. The window for intervention does not close.

The Silent Menopause Type has no perceptible symptoms, which sounds like the lucky outcome until you understand what is quietly accumulating. Bone density declining. LDL rising. Blood pressure trending up. Vaginal tissue thinning without pain yet. Insulin resistance establishing itself. The American Heart Association designated the menopausal transition as an independent cardiovascular disease risk factor in 2020. Women with this type are at disproportionate risk of delayed diagnosis on all of these fronts because they have no reason to seek care.

“Your mother’s, sister’s, neighbor’s, or best friend’s experience with menopause is likely to be quite different from yours, so interventions that helped them may not help you.”

What Does Heather Hirsch Actually Say About Hormones?

The Women’s Health Initiative published its alarming findings in 2002 and effectively froze menopause medicine for nearly two decades. Hormone therapy went from mainstream to radioactive. Women who had been managing their symptoms well were taken off HRT. And for twenty years, millions of women either suffered through debilitating symptoms or navigated a chaotic supplement market because no one in their care team felt safe prescribing.

Hirsch devotes a full chapter to what the WHI actually studied and what it did not. The WHI was not designed to evaluate hormone therapy for symptom relief. It studied women aged 50 to 79 (average age 63, many more than a decade past menopause) and looked at whether hormones could prevent chronic age-related disease. The breast cancer findings that made headlines applied to a specific synthetic hormone combination in a population much older than most women seeking perimenopause treatment.

The picture that emerged from subsequent analysis is different. For healthy women under 60 who are within 10 years of menopause onset, the benefits of hormone therapy generally outweigh the risks. This is now the position of the North American Menopause Society.

A few practical distinctions worth knowing:

Route matters. Transdermal estrogen (patches, gels, sprays) bypasses first-pass liver metabolism, which means lower clotting risk and less blood pressure effect than oral estrogen. For women with hypertension, high cholesterol, diabetes, or migraines, transdermal is the preferred route.
Progesterone applies to anyone with a uterus. Systemic estrogen without progestogen protection risks the uterine lining. Women who have had hysterectomies can use estrogen alone. Micronized progesterone (Prometrium) has a different risk profile than the synthetic progestin used in the WHI.
“Bioidentical” does not automatically mean safer. Standard pharmaceutical estradiol is chemically identical to the estrogen your body produced and is FDA-regulated. Compounded formulations are not. The term has been absorbed by marketing in ways that obscure this.
Contraindications are real. Estrogen-receptor-positive breast cancer, unprovoked blood clot history, prior heart attack or stroke are legitimate contraindications. Hirsch covers non-hormonal alternatives for every type.

Non-hormonal options get substantial treatment here, which matters because many women either cannot use HT or choose not to. For vasomotor symptoms, first-line options include SSRIs and SNRIs at low doses, gabapentin, and oxybutynin. For genitourinary symptoms, low-dose vaginal estrogen delivers local treatment with minimal systemic absorption and is often available even to women with estrogen-receptor-positive breast cancer history, with oncology guidance.

Why Does This Matter for Weight and Metabolism?

The weight piece is woven throughout the types rather than siloed into its own chapter. That is actually useful, because the metabolic changes of menopause are not uniform across women.

For the Full-Throttle Type, sleep disruption is often the primary driver of weight gain. When sleep is shattered by night sweats, cortisol rises, leptin falls, ghrelin rises, insulin resistance climbs, and the appetite regulation system stops working properly. Treating sleep first, Hirsch argues, partially resolves what many women experience as separate symptoms: the irritability, the weight creep, the afternoon brain fog. Getting sleep right reduces the complexity of everything else.

For the Silent Type, the metabolic changes are accumulating without any obvious signal. Insulin resistance is establishing itself quietly. Central fat is redistributing toward the abdomen (what Hirsch calls the “menopot”) regardless of whether the scale has moved. The absence of symptoms is not evidence that the body is not changing. This is the type that most benefits from proactive metabolic monitoring.

For the Mind-Altering Type, the connection runs through the adrenal axis. When the ovaries wind down, the brain turns to the adrenal glands for hormonal support. The adrenals respond with cortisol instead of estrogen, which worsens metabolic dysfunction, promotes abdominal fat storage, and contributes to the cognitive fog.

Hirsch’s four-pillar self-care model applies to all types: Mediterranean-style eating, weight-bearing exercise, consistent sleep hygiene, and active mental health management. On nutrition, she is specific where other books are vague. Adequate protein (at least 20g per meal for Sudden Type women recovering from surgery, for example), cardiovascular-protective eating for Silent Type women, and anti-inflammatory focus where chronic symptoms are driving tissue damage. The approach is not a diet; it is a metabolic maintenance framework calibrated to type.

Is Unlock Your Menopause Type Worth Reading?

Read this if you are in perimenopause or postmenopause and have not received satisfying answers from your current provider. It works especially well as a pre-appointment tool: reading it before a gynecology or primary care visit gives you the vocabulary to describe your type, ask specific questions, and push back if you are being dismissed. Women navigating premature or surgical menopause who have only seen generalists will get the most out of it.

Skip it if you are already working with a knowledgeable menopause specialist. You will be covering familiar ground. Women with complex medical histories (chronic autoimmune disease, eating disorder history, multiple psychiatric medications) may find the type-specific protocols require more individualization than the book can provide; in those cases it is a starting point, not a complete answer.

One caveat: the treatments Hirsch describes (specialist menopause clinic care, multiple medication trials, pelvic floor therapy, testosterone prescribing) are available to a relatively small subset of women. Many readers will absorb the framework and then encounter a generalist who does not share it. That is not a failure of the book. It is a failure of the healthcare system the book is written around. Go in prepared for the gap.

“After spending years putting other people first, some of my patients have embarked on new careers, taken up new hobbies or artistic pursuits, enjoyed exciting travel adventures, volunteered for meaningful causes, or discovered the best sex of their lives after menopause.”

If you have ever been told “this is just menopause” as if that were a complete sentence, this book was written for you.

Books Like Unlock Your Menopause Type

Book	Author	Best For
Menopause Bootcamp	Suzanne Gilberg-Lenz, MD	A warmer, more narrative take on the same evidence-based menopause landscape
Super Woman Rx	Taz Bhatia, MD	Similar typing/quiz approach, broader hormonal scope beyond menopause
The Menopause Brain	Lisa Mosconi, PhD	Deep neuroscience on cognitive changes; the research behind Hirsch’s Mind-Altering type
The Hormone Shift	Taz Bhatia, MD	Perimenopause-focused, integrative approach, practical protocols
The Science of Menopause	Mary Claire Haver, MD	Denser on clinical research; pairs well with Hirsch for a complete evidence picture

January 14, 2022

The Perimenopause Solution by Shahzadi Harper: Summary, Key Ideas & Review

Book in one sentence: A UK menopause specialist and a registered nutritionist make the case that perimenopause starts years earlier than most women suspect, that the symptoms are real and treatable, and that restriction is exactly the wrong response to what’s happening in your body.

What Is The Perimenopause Solution About?
Why Your Body Changed in Your Late 30s (Before You Had a Name for It)
What Perimenopause Actually Does to Appetite, Metabolism, and Mood
Why Eating Less Makes Everything Worse
Is The Perimenopause Solution Worth Reading?
Books Like The Perimenopause Solution

What Is The Perimenopause Solution About?

You’re in your early 40s. Your weight is doing something new, mostly around your middle. Sleep has gotten strange. Some mornings you wake at 3am, mind racing, no obvious reason. Your appetite feels unreliable, your mood snaps at things it never used to, and the brain that always felt sharp is suddenly foggy. You mention it to your doctor. Your periods are still regular, your bloodwork comes back normal, and you leave with a suggestion that maybe you’re a bit stressed.

What nobody told you is that you might already be in perimenopause. Not approaching it. Not “too young” for it. Actually in it, years before the hot flashes most people associate with the word.

The Perimenopause Solution was co-written by Dr. Shahzadi Harper, a UK women’s health physician and co-founder of The Harper Clinic, and Emma Bardwell, a registered nutritionist and member of the British Menopause Society. Both specialize in perimenopause. Both see these women in clinic every week. The book grew out of the conversations they kept having with patients who came in exhausted, dismissed, and convinced that what was happening to them was somehow their own fault, whether from stress they hadn’t managed well enough, weight they hadn’t controlled, or a general failure to hold things together.

It is a UK-focused book (the prescribing guidance references NHS and NICE, not FDA), but the underlying science travels. If you’ve been puzzling over changes in your body, appetite, or mood since your late 30s and no one has connected those dots for you, this book is likely to feel like an explanation you’ve been waiting for.

Why Your Body Changed in Your Late 30s (Before You Had a Name for It)

Here’s the thing most people don’t know: perimenopause and menopause are not the same event. Menopause is technically a single moment, the one-year mark after your last period, average age 51. Everything before that, often spanning four to ten years and sometimes starting in the early 40s, is perimenopause. It is the phase when hormones are actively fluctuating and declining, and it is when the vast majority of symptoms occur.

The confusion between the two words isn’t just semantic. It’s why a 43-year-old with regular cycles, crushing fatigue, and 3am waking gets told she’s “too young” instead of getting treated.

Blood tests often miss perimenopause entirely. Hormone levels fluctuate day to day during this phase, which means FSH can read normal on Tuesday and elevated on Thursday. In the UK, NICE guidelines now support diagnosing perimenopause on symptoms alone for women over 45, because the test result is not the diagnosis. The symptom picture is.

Testosterone is the hormone that falls first. By a woman’s 40s, testosterone levels have dropped roughly 50% from where they were in her 20s, a decline that predates the oestrogen drop most people associate with perimenopause. That fatigue that started years ago, the brain fog, the muscle loss, the flat energy that doesn’t respond to sleep: these are frequently testosterone deficiency symptoms, not character flaws, and not signs that you’re simply aging badly.

The timeline matters for ExcessMatters readers in particular. The weight changes, the hunger shifts, the mood-driven eating that might have started in your late 30s or early 40s, those weren’t random. They had a hormonal mechanism. Your appetite was not malfunctioning. Your body was changing in a way that had a name, and nobody had given you that name yet.

What Perimenopause Actually Does to Appetite, Metabolism, and Mood

Most people know about hot flashes and night sweats. What most people don’t know is that there are over 34 officially recognized perimenopause symptoms, spanning physical, psychological, cognitive, and urinary domains, and only about five of them get talked about. The gap between what women expect and what they experience is where years of misdiagnosis live.

The weight shift is real and documented. The book is direct about this: perimenopause causes changes to insulin sensitivity and metabolism that increase fat storage, particularly around the middle. Women who gained weight in a consistent pattern for years, then watched it start accumulating differently, are not imagining the change. The mechanism shifted.

Poor sleep compounds everything. As progesterone drops (one of the earliest declines in perimenopause), sleep quality deteriorates, and the 3am wake window becomes a signature symptom. Disrupted sleep elevates cortisol, which then disrupts progesterone further, which worsens sleep. The book points out directly that poor sleep increases hunger the next day, because of course it does.

The psychological symptoms are the piece most likely to go misdiagnosed. Menopausal Mood Disorder (MMD) is a hormonal phenomenon characterized by fluctuating (not persistently low) mood, loss of confidence, anxiety, cognitive slowing, and a flatness that women often describe as “not feeling like myself.” It gets misdiagnosed as clinical depression and treated with antidepressants. The authors are unambiguous: antidepressants are not first-line treatment for hormone-driven mood changes. For women who have spent time on SSRIs for symptoms that felt more physical than psychiatric, this chapter is worth reading.

“When you’re feeling low, you may tend to reach for carbohydrates and other high-sugar foods, so be aware of your personal triggers. Eat nutrient-dense food regularly throughout the day to maintain your food intake and energy balance. Not eating will depress your mood and further suppress the release of those happy hormones.”

The mood-food loop during perimenopause is not a willpower problem. Low mood drives carb cravings. Carb restriction depresses mood further and disrupts serotonin (90% of which is produced in the gut). The body asking for food is often the body trying to regulate hormones that have lost their footing.

Why Eating Less Makes Everything Worse

This is the section most directly relevant to anyone who has responded to perimenopausal body changes by restricting.

The book’s nutritional framework is built on one central mechanism: blood glucose instability amplifies every perimenopausal symptom. When blood sugar crashes, the body releases cortisol and adrenaline as a stress response. Cortisol disrupts progesterone (described here as the “grounding” hormone). Progesterone disruption worsens anxiety, disrupts sleep, increases irritability, and drives cravings. The resulting cravings, if met with refined sugar or simple carbs, spike blood glucose again and restart the cycle.

The practical intervention the authors recommend:

Protein at every meal to slow glucose absorption and maintain satiety
The Key 3 at each sitting: protein, fibre, and healthy fat together
No sweet foods as standalone snacks (pair fruit with nuts, eggs with toast)
Complex carbs replacing refined ones rather than carbs eliminated altogether
A short walk after meals to blunt the postprandial glucose spike

Note what’s not on that list. Calorie counting isn’t there. Elimination isn’t there. The authors are explicit that very low-carb approaches backfire for perimenopausal women: carbohydrates support serotonin production and calm the nervous system, and removing them entirely raises cortisol, worsens sleep, and compounds the hormonal pressure already present.

“Perimenopause — a time when your body is undergoing significant adjustments — is not a time for deprivation. No good can come from punishing your body into submission because it doesn’t look or feel like it used to any more. On the contrary, this is a time for positive nutrition — a time for nourishing yourself, filling up on the good stuff and making small dietary and lifestyle shifts that stack up over time. It’s about adding in rather than taking away.”

The gut layer adds another dimension. The estrobolome (the gut bacteria responsible for metabolizing used oestrogen) means that gut health is directly hormonal health. When the microbiome is disrupted, metabolized oestrogen can be reabsorbed into circulation, adding oestrogen imbalance on top of the fluctuations already occurring. The prescription: 30+ different plant foods per week, fermented foods, prebiotic fiber. Not a detox, not a cleanse, just feeding the microbiome consistently.

The book’s exercise hierarchy is worth noting too. Resistance training comes first, because oestrogen has anabolic properties and its decline accelerates muscle loss. Muscle loss slows resting metabolism, worsens insulin sensitivity, and accelerates the body composition changes that perimenopause already drives. The authors argue strength training should be prescribed. Walking (second in the hierarchy) is cardioprotective, accessible, and weight-bearing. High-intensity work without adequate recovery raises cortisol and can make symptoms worse.

Is The Perimenopause Solution Worth Reading?

Read this if you are in your late 30s or 40s and something has shifted (energy, sleep, weight, mood, cognitive sharpness) and you haven’t found an explanation that fits. Read it if you’ve been told your bloodwork is normal but you don’t feel normal. Read it if you’ve been offered antidepressants for symptoms that feel more physical than psychiatric. Read it if you’ve been restricting food to address weight changes that restriction keeps making worse.

Skip it if you’re primarily looking for US-specific prescribing guidance (the book references NHS systems throughout), or if you want a deep single-topic treatment of sleep, gut health, or nutrition as standalone subjects. The book covers a lot of ground across 15 chapters, and some sections go shallower than others because of it.

One caveat: The book is UK-specific in its HRT prescribing detail, and it was published in 2021. The broad science holds, but anyone acting on specific HRT recommendations should cross-reference with current guidance from their national menopause society (the Menopause Society in the US, the British Menopause Society in the UK). Guidelines have continued to evolve.

For ExcessMatters readers with a complicated relationship to food and dieting: the book contains a fat loss chapter (Chapter 15) that is notably respectful. It names the Health at Every Size movement, acknowledges that not every reader wants to address weight, and frames the nutrition guidance throughout as “adding in” rather than “taking away.” The perimenopausal lens here is useful even if weight isn’t the primary concern, because it explains why the body changes in the ways it does, and why deprivation makes those changes worse, not better. The appetite shifts, the mood-driven eating, the cravings that started in your late 30s are not personal failures. They are a physiological event with a name.

Books Like The Perimenopause Solution

Book	Author	Best For
It’s Not You It’s Your Hormones	Nicki Williams	Broader hormone picture including thyroid and adrenals alongside oestrogen
The Hormone Shift	Tamar Gur & Jessica Ritch	US-based, covers the full reproductive lifespan including perimenopause
Hormone Intelligence	Aviva Romm	Functional medicine approach, more alternative-medicine oriented
Menopause Bootcamp	Suzanne Gilberg-Lenz	Accessible, US-focused, integrative approach to the full menopause transition
The Menopause Brain	Lisa Mosconi	Deep neuroscience of oestrogen decline and cognitive health; the science behind brain fog

January 10, 2021

Sex, Lies, and Menopause by T.S. Wiley: Summary, Key Ideas & Review

Book in one sentence: Wiley argues that synthetic HRT causes harm while bioidentical hormones at high cyclical doses can restore pre-menopausal health. A critique that is partly right and partly dangerous, depending on which half you take seriously.

What Is Sex, Lies, and Menopause About?
What Does Wiley Actually Get Right?
What Is the Wiley Protocol (and Why Is It Controversial)?
The Hormone-Weight Connection Wiley Makes
Is Sex, Lies, and Menopause Worth Reading?
Books Like Sex, Lies, and Menopause

What Is Sex, Lies, and Menopause About?

In 2002, the Women’s Health Initiative stopped its major hormone trial early and set off a global panic. The drug being tested was PremPro (a cocktail of equine estrogen from mares’ urine and a synthetic progestin called medroxyprogesterone acetate). When the trial found elevated rates of breast cancer, heart disease, stroke, and dementia among users, millions of women stopped their hormone prescriptions overnight. Menopause medicine went conservative and stayed there for years.

T.S. Wiley published this book two years later, arguing that the panic was misguided. The WHI had tested one specific patented drug, and the findings were being applied to all hormone therapy, including bioidentical estradiol and natural progesterone, which are different molecules entirely. That critique, once considered fringe, is now mainstream. The book’s core pharmacological argument has been validated by subsequent research, including the KEEPS trial, the ELITE trial, and a decade of timing-hypothesis literature.

Here is where things get complicated: Wiley is not a doctor. She holds an anthropology degree. The book is co-authored with an oncologist (Julie Taguchi, M.D.) and a biochemist (Bent Formby, Ph.D.), which lends some credibility to the mechanistic sections. But the clinical conclusions Wiley draws from the science (including her own proprietary “Wiley Protocol”) have been specifically criticized by the FDA, the North American Menopause Society, and the Endocrine Society. Reading this book fairly requires holding two things simultaneously: some of what she says is correct and ahead of its time, and some of it is speculation dressed as certainty. This review will flag which is which.

What Does Wiley Actually Get Right?

A lot, as it turns out. At least in the first half of the book.

The WHI tested the wrong drug for the question being asked. Premarin is not estradiol. It is a mixture of ten different equine estrogens that the human body never encountered in evolution. MPA (synthetic progestin) binds to progesterone, estrogen, and androgen receptors, producing unpredictable effects throughout the body. Natural progesterone binds selectively to progesterone receptors. The PEPI trials, which Wiley cites accurately, found that the arm combining Premarin with natural progesterone had the best cardiovascular outcomes of all arms tested. Natural progesterone cannot be patented, so the finding received no industry follow-up and never became standard practice. The patentability-shapes-research argument is not conspiracy theory; it is well-documented in health policy literature entirely independent of Wiley.

Estrogen is not a reproductive hormone. It is a systemic maintenance molecule. Wiley’s most compelling passage cites over 300 bodily processes and more than 9,000 gene products that require estrogen to function, none of them directly involved in reproduction. Estrogen governs myelin maintenance in the brain, serotonin transport, GABA receptor sensitivity, insulin response, cardiovascular function, and bone density. When it disappears at menopause, the downstream effects are not incidental. They are predictable.

The chronobiology section is stronger than readers expect. The mechanism Wiley traces from artificial light at night through melatonin suppression to disrupted estrogen receptor cycling is grounded in established science. Melatonin gates estrogen receptor availability; artificial light chronically suppresses melatonin; without that signal, the monthly estrogen crescendo is blunted. Sleep disruption raises cortisol, drives insulin resistance, and accelerates perimenopausal dysfunction. Treating sleeplessness with a sleep aid while ignoring its hormonal drivers misses the point. Sleep disruption is not just a symptom of hormonal chaos. It feeds back to create more of it.

The evolutionary framing is also useful here, even if Wiley overextends it later. Human life expectancy at the turn of the 20th century was roughly 48 years for women. Evolution designed a hormonal system for organisms expected to reproduce and die, not for three or four decades of post-reproductive life. Menopause is not a designed second act. The body’s deterioration after estrogen loss is predictable entropy, not natural flourishing. Wiley’s sharpest rhetorical line: Margaret Mead, famous for coining the phrase “postmenopausal zest,” was receiving weekly estrogen injections from midlife until she died. The naturalistic fallacy applied to hormone decline does not survive contact with that fact.

What Is the Wiley Protocol (and Why Is It Controversial)?

This is where the book earns its polarized reception.

The Wiley Protocol is a proprietary compounding system that doses transdermal bioidentical estradiol and progesterone in a rising-and-falling 28-day cycle. The target: replicate the serum hormone levels of a woman aged 15 to 22. Peak estradiol targets are 350 to 500 pg/mL. For context, typical clinical practice targets 20 to 50 pg/mL. That is not a rounding difference. The Protocol requires a monthly withdrawal bleed as evidence that hormone peaks were sufficient, and it is only available through Wiley Registered Pharmacies in branded syringes.

The theoretical argument for cyclical dosing is sound. Estrogen drives cell proliferation and also, at peak levels, creates the progesterone receptors needed to receive progesterone’s apoptotic (cell-death) signal. Without the estrogen peak, progesterone receptors never appear. Cells remain in chronic low-level growth without the counterweight. Static daily-dose HRT, even bioidentical daily estradiol, does not replicate this cycle. The mechanism for why rhythmic dosing might matter is real. The specific doses the Protocol uses are not validated.

Here is what the major medical bodies have actually said:

The FDA has sent warning letters to compounding pharmacies carrying the Protocol for unapproved drug claims
The North American Menopause Society has specifically criticized doses “far above clinical practice norms without safety data”
The Endocrine Society has flagged the cancer prevention claims as unproven
The “period forever” requirement (inducing monthly uterine lining buildup in postmenopausal women) is considered a potential cancer risk by many clinicians

No randomized controlled trial has tested the Wiley Protocol’s safety or efficacy. “Bioidentical” describes molecular identity, not dose safety. High doses of natural estradiol still carry risks that do not disappear because the molecule matches what the body produces. Wiley the anthropologist interprets the mechanistic research with a clear agenda and without the epistemic humility that clinical uncertainty requires. The co-authors with actual clinical credentials (Taguchi and Formby) validate the science of individual mechanisms, not the Protocol’s dosing targets.

The causal chains Wiley builds are also a problem. She links artificial light to breast cancer, anovulatory cycles to Alzheimer’s, sleep disruption to oncogenesis, and autoimmunity to cancer-compensatory antibody production. Each individual link may have some support. The complete chain as a proven causal mechanism does not. The autoimmunity theory in particular (that postmenopausal arthritis and psoriasis are functioning as a Herceptin-equivalent anti-cancer system, and that treating them with steroids removes cancer protection) is intellectually interesting and almost entirely speculative.

The Hormone-Weight Connection Wiley Makes

For the ExcessMatters audience, this is the relevant thread to pull.

Wiley’s perimenopausal model is clinically useful even if her protocol is not. Perimenopause, she argues, is mechanistically analogous to early puberty. In both states: estrogen is low and fluctuating, testosterone is rising (via adrenal drive), FSH is elevated and erratic, sleep is disrupted, insulin resistance appears, and ovulation is absent. The difference is that in puberty the system is building toward the first ovulatory estrogen peak. In perimenopause, there are no eggs left to generate that peak. The loop never completes.

The result is a body stuck in anovulatory mode: enough estrogen to drive cell growth and hunger signaling, without the progesterone peak to balance it. Insulin resistance climbs. Cortisol stays elevated. The weight gain of perimenopause is not a caloric failure. It is a hormonal environment. Chasing it with restriction tends to raise cortisol further, which makes the insulin resistance worse.

The chronobiology piece connects here too. Poor sleep raises ghrelin (hunger hormone) and drops leptin (satiety hormone), independently of calories consumed. Perimenopausal sleep disruption is a driver of weight gain through this route, not just a side effect of it. Fixing the sleep environment (light exposure, sleep timing, cortisol management) is a metabolic intervention, not just a wellness recommendation.

What Wiley gets right on this topic: hormones drive weight in perimenopause, and treating the symptoms without addressing the hormonal environment is incomplete. What she overstates: the specific idea that the Wiley Protocol’s doses are the correct intervention for this, without any clinical trial data to support it.

Is Sex, Lies, and Menopause Worth Reading?

Read this if you want to understand the WHI controversy in depth, you’re evaluating hormone therapy options and want the bioidentical/synthetic distinction explained in detail, or you’re interested in the chronobiology of sleep and hormones. Read the first half critically and carefully.

Skip it if you need clinical guidance on what to actually do about menopause. This book is not a prescription guide, and using it as one carries real risk. For evidence-based HRT guidance, Menopause Bootcamp by Suzanne Gilberg-Lenz is a better starting point. For the mainstream academic defense of hormone therapy (without Wiley’s dosing extremism), Estrogen Matters by Bluming and Tavris covers the same WHI critique with far more evidentiary rigor.

One caveat: Wiley’s argument that pharmaceutical economics distort which treatments get studied is correct and important. But the conclusion she draws from it (that the Wiley Protocol must therefore be safe because it hasn’t been funded to be studied) is a logical gap wide enough to drive a truck through. The absence of industry funding for a treatment is not evidence of that treatment’s safety. It is evidence of how research funding works.

The book’s most honest summary may be this: the difference between bioidentical and synthetic hormones matters, rhythmic dosing is theoretically superior to static dosing, and pharmaceutical economics do shape which treatments get studied. None of that requires accepting the Wiley Protocol as proven, or accepting high-dose untested therapy as safe because the argument for it is compelling. Compelling arguments and proven safety are different things.

Books Like Sex, Lies, and Menopause

Book	Author	Best For
Menopause Bootcamp	Suzanne Gilberg-Lenz, M.D.	Evidence-based HRT guidance without the controversy
The Hormone Myth	Robyn Stein DeLuca	Healthy skepticism about hormone claims
Hormone Intelligence	Aviva Romm, M.D.	Integrative balance on women’s hormones
The Power of Hormones	Max Nieuwdorp	Real endocrinology, accessible and credible
The Science of Menopause	Mary Claire Haver, M.D.	Clinical facts, current guidelines

January 8, 2003